Sartorius | SRT3 - Current Assets

Stock Price
228.30
Daily Change
-10.70 -4.48%
Monthly
-12.19%
Yearly
-4.95%
Q1 Forecast
230.71

Sartorius reported EUR1.72B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akebia Therapeutics USD 258.34M 23.68M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Sartorius EUR 1.72B 449M Sep/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025